Literature DB >> 5420238

Effect of RA233 on platelet function in vitro.

A A Hassanein, A G Turpie, G P McNicol, A S Douglas.   

Abstract

RA233, a new pyrimido-pyrimidine compound, is a powerful inhibitor of platelet function tested in vitro; it inhibits calcium and adenosine diphosphate (A.D.P.)-induced platelet aggregation, inhibits the retention of platelets by glass beads, decreases the release of platelet factor 3 by kaolin, and inhibits clot retraction. In some in-vitro systems RA233 is significantly more potent that its analogue RA433 in inhibiting platelet function.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5420238      PMCID: PMC1699949          DOI: 10.1136/bmj.2.5701.83

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

Review 1.  THROMBOSIS.

Authors:  J F MUSTARD; H C ROWSELL; E A MURPHY
Journal:  Am J Med Sci       Date:  1964-10       Impact factor: 2.378

2.  EFFECT OF ANTICOAGULANT DRUGS ON PLATELET AGGREGATION IN THE CHANDLER'S TUBE.

Authors:  G M CUNNINGHAM; G P MCNICOL; A S DOUGLAS
Journal:  Lancet       Date:  1965-04-03       Impact factor: 79.321

3.  Platelet clumping in vivo.

Authors:  A J HONOUR; J R MITCHELL
Journal:  Nature       Date:  1963-03-09       Impact factor: 49.962

4.  Factors influencing thrombus formation in vivo.

Authors:  J F MUSTARD; E A MURPHY; H C ROWSELL; H G DOWNIE
Journal:  Am J Med       Date:  1962-11       Impact factor: 4.965

5.  Effect of a pyrimido-pyrimidine compound on platelet behaviour in vitro and in vivo.

Authors:  R S Elkeles; J R Hampton; A J Honour; J R Mitchell; J S Prichard
Journal:  Lancet       Date:  1968-10-05       Impact factor: 79.321

6.  Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.

Authors:  J M Sullivan; D E Harken; R Gorlin
Journal:  N Engl J Med       Date:  1968-09-12       Impact factor: 91.245

7.  The effect on dipyridamole on platelet aggregation and adhesiveness.

Authors:  G R Gray; P A Wilson; A S Douglas
Journal:  Scott Med J       Date:  1968-12       Impact factor: 0.729

8.  Effect of dipyridamole on human platelet behaviour.

Authors:  P R Emmons; M J Harrison; A J Honour; J R Mitchell
Journal:  Lancet       Date:  1965-09-25       Impact factor: 79.321

9.  Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit.

Authors:  P R Emmons; M J Harrison; A J Honour; J R Mitchell
Journal:  Nature       Date:  1965-10-16       Impact factor: 49.962

10.  Thrombo-embolism and increased platelet adhesiveness in post-splenectomy thrombocytosis.

Authors:  J Hirsh; J A McBride; J V Dacie
Journal:  Australas Ann Med       Date:  1966-05
View more
  5 in total

Review 1.  Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.

Authors:  D Ogston; A S Douglas
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 2.  Platelets, thrombosis and drugs.

Authors:  J F Mustard; M A Packham
Journal:  Drugs       Date:  1975       Impact factor: 9.546

3.  Failure of orally administered RA233 to influence B16 melanoma growth or metastasis.

Authors:  C W Stackpole; D M Fornabaio; A L Alterman
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

4.  Effects of RA 233 treatment on the adhesive, invasive and metastatic properties of 13762NF rat mammary tumor cells.

Authors:  R B Lichtner; L J Erkell; V Schirrmacher; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

5.  Effect in vitro on platelet function of two compounds developed from the pyrimido-pyrimidines.

Authors:  S D Slater; A G Turpie; A S Douglas; G P McNicol
Journal:  J Clin Pathol       Date:  1972-05       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.